Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial
Diabetes Care - United States
doi 10.2337/dc18-1491
Full Text
Open PDFAbstract
Available in full text
Date
November 28, 2018
Authors
Publisher
American Diabetes Association